Lilly To Pay Miss. $18.5M Over Zyprexa Marketing
Eli Lilly and Co. Inc. has agreed to pay Mississippi $18.5 million to settle the state's allegations that the drugmaker marketed its antipsychotic Zyprexa for off-label uses and failed to reveal...To view the full article, register now.
Already a subscriber? Click here to view full article